Novartis Investigative Site

Newcastle upon Tyne, Newcastle NE7 7DN

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Non-Small Cell Lung Cancer, Pulmonary Arterial Hypertension

Studies at this site

• Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) — Stopped early